{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T03:50:39Z","timestamp":1781754639062,"version":"3.54.5"},"reference-count":110,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.cld.2019.06.002","type":"journal-article","created":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T00:50:26Z","timestamp":1565139026000},"page":"659-682","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Ascites and Hepatorenal Syndrome"],"prefix":"10.1016","volume":"23","author":[{"given":"Danielle","family":"Adebayo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuet Fong","family":"Neong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cld.2019.06.002_bib1","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/j.gastro.2007.05.024","article-title":"Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis","volume":"133","author":"Ripoll","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2019.06.002_bib2","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJMra0809139","article-title":"Renal failure in cirrhosis","volume":"361","author":"Gines","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cld.2019.06.002_bib3","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.1840080532","article-title":"Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis","volume":"8","author":"Schrier","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2019.06.002_bib4","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.jhep.2015.07.004","article-title":"Mechanisms of decompensation and organ failure in cirrhosis: from peripheral arterial vasodilation to systemic inflammation hypothesis","volume":"63","author":"Bernardi","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2019.06.002_bib5","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/liv.13589","article-title":"The pathophysiology of arterial vasodilatation and hyperdynamic circulation in cirrhosis","volume":"38","author":"Moller","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.cld.2019.06.002_bib6","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1002\/hep.27343","article-title":"Molecular pathophysiology of portal hypertension","volume":"61","author":"Fernandez","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2019.06.002_bib7","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41395-018-0185-6","article-title":"Refractory ascites in liver cirrhosis","volume":"114","author":"Adebayo","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2019.06.002_bib8","first-page":"1","article-title":"Hepatorenal syndrome in cirrhosis: diagnostic, pathophysiological, and therapeutic aspects","volume":"16","author":"Busk","year":"2016","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2019.06.002_bib9","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41572-018-0035-2","article-title":"Hepatorenal syndrome","volume":"4","author":"Gines","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.cld.2019.06.002_bib10","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.mehy.2012.03.032","article-title":"The cardiorenal link in advanced cirrhosis","volume":"79","author":"Krag","year":"2012","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.cld.2019.06.002_bib11","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1681\/ASN.2006111302","article-title":"Decreased effective blood volume in edematous disorders: what does this mean?","volume":"18","author":"Schrier","year":"2007","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.cld.2019.06.002_bib12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1053\/j.gastro.2007.10.055","article-title":"Relationship between activation of the sympathetic nervous system and renal blood flow autoregulation in cirrhosis","volume":"134","author":"Stadlbauer","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2019.06.002_bib13","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1111\/liv.13893","article-title":"Hepatorenal syndrome in the era of acute kidney injury","volume":"38","author":"Sole","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.cld.2019.06.002_bib14","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1111\/j.1572-0241.2002.05791.x","article-title":"Small intestinal bacterial overgrowth in human cirrhosis is associated with systemic endotoxemia","volume":"97","author":"Bauer","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2019.06.002_bib15","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nature13568","article-title":"Alterations of the human gut microbiome in liver cirrhosis","volume":"513","author":"Qin","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.cld.2019.06.002_bib16","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1002\/hep.26755","article-title":"Novel inflammatory biomarkers of portal pressure in compensated cirrhosis patients","volume":"59","author":"Buck","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2019.06.002_bib17","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.cyto.2015.10.006","article-title":"Immune dysfunction in cirrhosis: distinct cytokines phenotypes according to cirrhosis severity","volume":"77","author":"Dirchwolf","year":"2016","journal-title":"Cytokine"},{"key":"10.1016\/j.cld.2019.06.002_bib18","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1002\/hep.28740","article-title":"Systemic inflammation in decompensated cirrhosis: characterization and role in acute-on-chronic liver failure","volume":"64","author":"Claria","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2019.06.002_bib19","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jhep.2011.11.024","article-title":"Prevention of acute kidney injury in a rodent model of cirrhosis following selective gut decontamination is associated with reduced renal TLR4 expression","volume":"56","author":"Shah","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2019.06.002_bib20","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1053\/j.gastro.2007.06.065","article-title":"Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis","volume":"133","author":"Fernandez","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2019.06.002_bib21","doi-asserted-by":"crossref","first-page":"186","DOI":"10.7326\/0003-4819-139-3-200308050-00008","article-title":"The effect of selective intestinal decontamination on the hyperdynamic circulatory state in cirrhosis. A randomized trial","volume":"139","author":"Rasaratnam","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cld.2019.06.002_bib22","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1111\/liv.14037","article-title":"Characterization of inflammatory response in hepatorenal syndrome. relationship with kidney outcome and survival","volume":"39","author":"Sole","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.cld.2019.06.002_bib23","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/hep.21443","article-title":"Renal failure and bacterial infections in patients with cirrhosis: epidemiology and clinical features","volume":"45","author":"Fasolato","year":"2007","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"10.1016\/j.cld.2019.06.002_bib24","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/liv.13645","article-title":"Infections complicating cirrhosis","volume":"38","author":"Piano","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.cld.2019.06.002_bib25","first-page":"1310","article-title":"Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis","volume":"56","author":"Salerno","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.cld.2019.06.002_bib26","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.cld.2012.03.004","article-title":"Ascites","volume":"16","author":"Gordon","year":"2012","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.cld.2019.06.002_bib27","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jhep.2010.05.004","article-title":"EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis","volume":"53","year":"2010","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2019.06.002_bib28","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","article-title":"Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies","volume":"44","author":"D'Amico","year":"2006","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2019.06.002_bib29","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/j.1478-3231.2010.02272.x","article-title":"Refractory ascites: pathogenesis, definition and therapy of a severe complication in patients with cirrhosis","volume":"30","author":"Salerno","year":"2010","journal-title":"Liver Int"},{"key":"10.1016\/j.cld.2019.06.002_bib30","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1053\/jhep.2003.50315","article-title":"The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club","volume":"38","author":"Moore","year":"2003","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"10.1016\/j.cld.2019.06.002_bib31","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s12072-017-9815-0","article-title":"Management of ascites and hepatorenal syndrome","volume":"12","author":"Piano","year":"2018","journal-title":"Hepatol Int"},{"key":"10.1016\/j.cld.2019.06.002_bib32","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000084723","article-title":"Refractory ascites","volume":"23","author":"Cardenas","year":"2005","journal-title":"Dig Dis"},{"key":"10.1016\/j.cld.2019.06.002_bib33","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1440-1746.2011.06925.x","article-title":"Management of ascites in cirrhosis","volume":"27","author":"Wong","year":"2012","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2019.06.002_bib34","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1111\/liv.12583","article-title":"Adherence to a moderate sodium restriction diet in outpatients with cirrhosis and ascites: a real-life cross-sectional study","volume":"35","author":"Morando","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.cld.2019.06.002_bib35","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1136\/gut.2008.176495","article-title":"Combined versus sequential diuretic treatment of ascites in non-azotaemic patients with cirrhosis: results of an open randomised clinical trial","volume":"59","author":"Angeli","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.cld.2019.06.002_bib36","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1056\/NEJMra035021","article-title":"Management of cirrhosis and ascites","volume":"350","author":"Gines","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cld.2019.06.002_bib37","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.3748\/wjg.v12.i9.1403","article-title":"Long-term albumin infusion improves survival in patients with cirrhosis and ascites: an unblinded randomized trial","volume":"12","author":"Romanelli","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cld.2019.06.002_bib38","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jhep.2016.11.001","article-title":"Beta adrenergic blockade and decompensated cirrhosis","volume":"66","author":"Reiberger","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2019.06.002_bib39","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1007\/s10620-016-4140-3","article-title":"Albumin may prevent the morbidity of paracentesis-induced circulatory dysfunction in cirrhosis and refractory ascites: a pilot study","volume":"61","author":"Tan","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cld.2019.06.002_bib40","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.dld.2004.03.014","article-title":"The rational use of albumin in patients with cirrhosis and ascites. A Delphi study for the attainment of a consensus on prescribing standards","volume":"36","author":"Gentilini","year":"2004","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.cld.2019.06.002_bib41","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0168-8278(99)80194-9","article-title":"Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial","volume":"30","author":"Gentilini","year":"1999","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2019.06.002_bib42","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/S0168-8278(99)80329-8","article-title":"Albumin substitution improves urinary sodium excretion and diuresis in patients with liver cirrhosis and refractory ascites","volume":"31","author":"Schindler","year":"1999","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2019.06.002_bib43","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1016\/S0140-6736(18)30840-7","article-title":"Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial","volume":"391","author":"Caraceni","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.cld.2019.06.002_bib44","doi-asserted-by":"crossref","first-page":"816","DOI":"10.7326\/0003-4819-122-11-199506010-00002","article-title":"Transjugular intrahepatic portosystemic stent shunt: effects on hemodynamics and sodium homeostasis in cirrhosis and refractory ascites","volume":"122","author":"Wong","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cld.2019.06.002_bib45","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/jgh.12725","article-title":"Long-term clinical outcome of patients with cirrhosis and refractory ascites treated with transjugular intrahepatic portosystemic shunt insertion","volume":"30","author":"Tan","year":"2015","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2019.06.002_bib46","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1053\/j.gastro.2007.06.020","article-title":"Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data","volume":"133","author":"Salerno","year":"2007","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.cld.2019.06.002_bib47","article-title":"TIPS versus paracentesis for cirrhotic patients with refractory ascites","author":"Saab","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cld.2019.06.002_bib48","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1053\/j.gastro.2016.09.016","article-title":"Transjugular intrahepatic portosystemic shunts with covered stents increase transplant-free survival of patients with cirrhosis and recurrent ascites","volume":"152","author":"Bureau","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2019.06.002_bib49","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1111\/liv.13615","article-title":"ePTFE-TIPS vs repetitive LVP plus albumin for the treatment of refractory ascites in patients with cirrhosis","volume":"38","author":"Bucsics","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.cld.2019.06.002_bib50","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/MEG.0b013e328359a759","article-title":"Reversal of sarcopenia predicts survival after a transjugular intrahepatic portosystemic stent","volume":"25","author":"Tsien","year":"2013","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2019.06.002_bib51","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.cgh.2018.03.027","article-title":"Cost effectiveness of early insertion of transjugular intrahepatic portosystemic shunts for recurrent ascites","volume":"16","author":"Shen","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2019.06.002_bib52","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/hep.27210","article-title":"Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver","volume":"60","author":"Vilstrup","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2019.06.002_bib53","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.cgh.2018.01.029","article-title":"Under-dilated TIPS associate with efficacy and reduced encephalopathy in a prospective, non-randomized study of patients with cirrhosis","volume":"16","author":"Schepis","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2019.06.002_bib54","doi-asserted-by":"crossref","first-page":"985141","DOI":"10.1155\/2014\/985141","article-title":"Hemorrhagic complications of paracentesis: a systematic review of the literature","volume":"2014","author":"Sharzehi","year":"2014","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.cld.2019.06.002_bib55","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.dld.2005.07.009","article-title":"Should bleeding tendency deter abdominal paracentesis?","volume":"37","author":"Lin","year":"2005","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.cld.2019.06.002_bib56","first-page":"191","article-title":"Does the evidence support a survival benefit of albumin infusion in patients with cirrhosis undergoing large-volume paracentesis?","volume":"11","author":"Bernardi","year":"2017","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2019.06.002_bib57","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1002\/hep.24786","article-title":"Albumin infusion in patients undergoing large-volume paracentesis: a meta-analysis of randomized trials","volume":"55","author":"Bernardi","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2019.06.002_bib58","first-page":"394","article-title":"Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diuretic-resistant ascites","volume":"92","author":"Peltekian","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2019.06.002_bib59","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/0016-5085(88)90691-9","article-title":"Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis","volume":"94","author":"Gines","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2019.06.002_bib60","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1053\/jhep.2003.50169","article-title":"Randomized trial comparing albumin and saline in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients with ascites","volume":"37","author":"Sola-Vera","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2019.06.002_bib61","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1478-3231.2005.01188.x","article-title":"Comparison of outcome in patients with cirrhosis and ascites following treatment with albumin or a synthetic colloid: a randomised controlled pilot trail","volume":"26","author":"Moreau","year":"2006","journal-title":"Liver Int"},{"key":"10.1016\/j.cld.2019.06.002_bib62","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/hep.26359","article-title":"Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012","volume":"57","author":"Runyon","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2019.06.002_bib63","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1136\/gut.50.1.90","article-title":"Comparison of the effect of terlipressin and albumin on arterial blood volume in patients with cirrhosis and tense ascites treated by paracentesis: a randomised pilot study","volume":"50","author":"Moreau","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.cld.2019.06.002_bib64","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jhep.2017.06.010","article-title":"Alfapump\u00ae system vs. large volume paracentesis for refractory ascites: a multicenter randomized controlled study","volume":"67","author":"Bureau","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2019.06.002_bib65","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.jhep.2012.12.020","article-title":"Automated low flow pump system for the treatment of refractory ascites: a multi-center safety and efficacy study","volume":"58","author":"Bellot","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2019.06.002_bib66","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1007\/s11136-018-1813-8","article-title":"Patients with refractory ascites treated with alfapump\u00ae system have better health-related quality of life as compared to those treated with large volume paracentesis: the results of a multicenter randomized controlled study","volume":"27","author":"Stepanova","year":"2018","journal-title":"Qual Life Res"},{"key":"10.1016\/j.cld.2019.06.002_bib67","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/lt.24763","article-title":"Effects of alfapump system on kidney and circulatory function in patients with cirrhosis and refractory ascites","volume":"23","author":"Sola","year":"2017","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cld.2019.06.002_bib68","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/gastro\/gox010","article-title":"Ascites, refractory ascites and hyponatremia in cirrhosis","volume":"5","author":"Fortune","year":"2017","journal-title":"Gastroenterol Rep"},{"key":"10.1016\/j.cld.2019.06.002_bib69","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1053\/jlts.2002.35927","article-title":"The new liver allocation system: moving toward evidence-based transplantation policy","volume":"8","author":"Freeman","year":"2002","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cld.2019.06.002_bib70","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0016-5085(93)90031-7","article-title":"Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites","volume":"105","author":"Gines","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2019.06.002_bib71","first-page":"647","article-title":"Refractory ascites: pathogenesis, clinical impact, and management","volume":"5","author":"Siqueira","year":"2009","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2019.06.002_bib72","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/hep.1840400409","article-title":"Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death","volume":"40","author":"Heuman","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2019.06.002_bib73","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/lt.22218","article-title":"Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk","volume":"17","author":"Somsouk","year":"2011","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cld.2019.06.002_bib74","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1097\/01.sla.0000164077.77912.98","article-title":"Analysis of long-term outcomes of 3200 liver transplantations over two decades: a single-center experience","volume":"241","author":"Busuttil","year":"2005","journal-title":"Ann Surg"},{"key":"10.1016\/j.cld.2019.06.002_bib75","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0168-8278(00)00011-8","article-title":"A\u00a0prognostic model for predicting survival in cirrhosis with ascites","volume":"34","author":"Fernandez-Esparrach","year":"2001","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2019.06.002_bib76","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5455\/medarh.2016.70.48-52","article-title":"Prognostic significance of ascites and serum sodium in patients with low MELD scores","volume":"70","author":"Prohic","year":"2016","journal-title":"Med Arch"},{"key":"10.1016\/j.cld.2019.06.002_bib77","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.20517","article-title":"Serum sodium predicts mortality in patients listed for liver transplantation","volume":"41","author":"Biggins","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2019.06.002_bib78","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S1665-2681(19)31491-7","article-title":"Causes of renal failure in patients with decompensated cirrhosis and its impact in hospital mortality","volume":"11","author":"Carvalho","year":"2012","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.cld.2019.06.002_bib79","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1002\/hep.22605","article-title":"Acute kidney injury in cirrhosis","volume":"48","author":"Garcia-Tsao","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2019.06.002_bib80","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/gutjnl-2014-308874","article-title":"Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites","volume":"64","author":"Angeli","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.cld.2019.06.002_bib81","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1136\/gut.2010.236133","article-title":"Working Party proposal for a revised classification system of renal dysfunction in patients with cirrhosis","volume":"60","author":"Wong","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.cld.2019.06.002_bib82","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jhep.2013.03.039","article-title":"Evaluation of the Acute Kidney Injury Network criteria in hospitalized patients with cirrhosis and ascites","volume":"59","author":"Piano","year":"2013","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2019.06.002_bib83","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"EASL clinical practice guidelines for the management of patients with decompensated cirrhosis","volume":"69","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2019.06.002_bib84","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/hep.26980","article-title":"Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury","volume":"60","author":"Belcher","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2019.06.002_bib85","doi-asserted-by":"crossref","first-page":"e0128145","DOI":"10.1371\/journal.pone.0128145","article-title":"Analysis of a urinary biomarker panel for clinical outcomes assessment in cirrhosis","volume":"10","author":"Ariza","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.cld.2019.06.002_bib86","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1055\/s-0038-1661372","article-title":"Renal function in cirrhosis: a critical review of available tools","volume":"38","author":"Piano","year":"2018","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.cld.2019.06.002_bib87","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.jhep.2016.10.024","article-title":"New diagnostic criteria and management of acute kidney injury","volume":"66","author":"Wong","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2019.06.002_bib88","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1053\/j.gastro.2008.02.014","article-title":"A\u00a0randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome","volume":"134","author":"Sanyal","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2019.06.002_bib89","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jhep.2007.04.010","article-title":"Noradrenalin vs terlipressin in patients with hepatorenal syndrome: a prospective, randomized, unblinded, pilot study","volume":"47","author":"Alessandria","year":"2007","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2019.06.002_bib90","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/hep.27709","article-title":"Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: a randomized trial","volume":"62","author":"Cavallin","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2019.06.002_bib91","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S2468-1253(16)30157-1","article-title":"Comparative efficacy of pharmacological strategies for management of type 1 hepatorenal syndrome: a systematic review and network meta-analysis","volume":"2","author":"Facciorusso","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2019.06.002_bib92","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1053\/j.gastro.2016.02.026","article-title":"Terlipressin plus albumin is more effective than albumin alone in improving renal function in patients with cirrhosis and hepatorenal syndrome type 1","volume":"150","author":"Boyer","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2019.06.002_bib93","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1111\/apt.14052","article-title":"Reversal of hepatorenal syndrome type 1 with terlipressin plus albumin vs. placebo plus albumin in a pooled analysis of the OT-0401 and REVERSE randomised clinical studies","volume":"45","author":"Sanyal","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cld.2019.06.002_bib94","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/hep.28396","article-title":"Terlipressin given by continuous intravenous infusion versus intravenous boluses in the treatment of hepatorenal syndrome: a randomized controlled study","volume":"63","author":"Cavallin","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2019.06.002_bib95","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.jhep.2012.01.012","article-title":"Noradrenaline vs. terlipressin in the treatment of hepatorenal syndrome: a randomized study","volume":"56","author":"Singh","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2019.06.002_bib96","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/j.cgh.2018.01.035","article-title":"Association between grade of acute on chronic liver failure and response to terlipressin and albumin in patients with hepatorenal syndrome","volume":"16","author":"Piano","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2019.06.002_bib97","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1097\/MCG.0b013e318188947c","article-title":"Combination treatment with octreotide, midodrine, and albumin improves survival in patients with type 1 and type 2 hepatorenal syndrome","volume":"43","author":"Skagen","year":"2009","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.cld.2019.06.002_bib98","first-page":"129","article-title":"Transjugular intrahepatic portosystemic shunt worsens the hyperdynamic circulatory state of the cirrhotic patient: preliminary report of a prospective study","volume":"19","author":"Azoulay","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2019.06.002_bib99","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/hep.20262","article-title":"Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome","volume":"40","author":"Wong","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2019.06.002_bib100","doi-asserted-by":"crossref","first-page":"R23","DOI":"10.1186\/cc11188","article-title":"Hepatorenal syndrome: the 8th international consensus conference of the Acute Dialysis Quality Initiative (ADQI) Group","volume":"16","author":"Nadim","year":"2012","journal-title":"Crit Care"},{"key":"10.1016\/j.cld.2019.06.002_bib101","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.jcrc.2015.05.006","article-title":"Role of renal replacement therapy in patients with type 1 hepatorenal syndrome receiving combination treatment of vasoconstrictor plus albumin","volume":"30","author":"Zhang","year":"2015","journal-title":"J\u00a0Crit Care"},{"key":"10.1016\/j.cld.2019.06.002_bib102","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/hep.20687","article-title":"MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation","volume":"41","author":"Alessandria","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2019.06.002_bib103","doi-asserted-by":"crossref","first-page":"5362810","DOI":"10.1155\/2018\/5362810","article-title":"Clinical outcomes after liver transplantation for hepatorenal syndrome: a systematic review and meta-analysis","volume":"2018","author":"Utako","year":"2018","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.cld.2019.06.002_bib104","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/lt.24049","article-title":"Outcomes of patients with cirrhosis and hepatorenal syndrome type 1 treated with liver transplantation","volume":"21","author":"Wong","year":"2015","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cld.2019.06.002_bib105","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1056\/NEJMoa021744","article-title":"Chronic renal failure after transplantation of a nonrenal organ","volume":"349","author":"Ojo","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cld.2019.06.002_bib106","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1053\/jlts.2003.50113","article-title":"Independent risk factors and natural history of renal dysfunction in liver transplant recipients","volume":"9","author":"Pawarode","year":"2003","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cld.2019.06.002_bib107","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1097\/TP.0000000000000557","article-title":"Pretransplant type 2 hepatorenal syndrome is associated with persistently impaired renal function after liver transplantation","volume":"99","author":"Tan","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.cld.2019.06.002_bib108","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jamcollsurg.2018.12.003","article-title":"Effect of renal diagnosis on survival in simultaneous liver-kidney transplantation","volume":"228","author":"Cannon","year":"2019","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.cld.2019.06.002_bib109","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cgh.2012.11.007","article-title":"Albumin infusion improves outcomes of patients with spontaneous bacterial peritonitis: a meta-analysis of randomized trials","volume":"11","author":"Salerno","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2019.06.002_bib110","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/MNH.0000000000000260","article-title":"Simultaneous liver kidney transplantation","volume":"25","author":"Formica","year":"2016","journal-title":"Curr Opin Nephrol Hypertens"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326119300418?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326119300418?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T17:55:57Z","timestamp":1761069357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326119300418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":110,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S1089326119300418"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2019.06.002","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ascites and Hepatorenal Syndrome","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2019.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}